Diabetes cell therapy (Living Cell Technologies)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDiabetes cell therapy (Living Cell Technologies)
Drug Alias NameImmunoprotected (alginate-encapsulated) porcine islets - Diatranz Otsuka LimitedDiabeCell
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionPancreatic beta cell replacements
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesLiving Cell Technologies
China Registration ClassN/A

Develop Information

Active CompaniesDiatranz Otsuka LtdLiving Cell Technologies
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A